Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): An Updated Overview and Pharmacotherapeutics

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Medicinal Chemistry

• Publication date

  2015-08-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2161-0444.1000287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro)

  2015cited by this paper
• Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV

  2015cited by this paper
• Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response

  2015cited by this paper
• Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease

  2015cited by this paper
• Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)

  2015cited by this paper
• Mouse Dipeptidyl Peptidase 4 Is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus Infection

  2014cited by this paper
• IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms

  2014cited by this paper
• Replicative Capacity of MERS Coronavirus in Livestock Cell Lines

  2014cited by this paper
• Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

  2014cited by this paper
• Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus.

  2014cited by this paper
• Testing of Middle East Respiratory Syndrome Coronavirus Replication Inhibitors for the Ability To Block Viral Entry

  2014cited by this paper
• Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

  2014cited by this paper
• Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus

  2014cited by this paper
• Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?

  2014cited by this paper
• Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus

  2014cited by this paper
• Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies

  2014cited by this paper
• Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

  2014cited by this paper
• IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion

  2014cited by this paper
• Coronaviruses Resistant to a 3C-Like Protease Inhibitor Are Attenuated for Replication and Pathogenesis, Revealing a Low Genetic Barrier but High Fitness Cost of Resistance

  2014cited by this paper
• Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses

  2014cited by this paper
• Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein

  2014cited by this paper
• X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases

  2014cited by this paper
• Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

  2014cited by this paper
• Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

  2014cited by this paper
• IFITM Proteins Restrict Viral Membrane Hemifusion

  2013cited by this paper
• The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters

  2013cited by this paper
• IFITMs Restrict the Replication of Multiple Pathogenic Viruses

  2013cited by this paper
• Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures

  2013cited by this paper
• Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

  2013influential reference
• Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26

  2013cited by this paper
• A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines

  2013cited by this paper
• The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease

  2013influential reference
• An Animal Model of MERS Produced by Infection of Rhesus Macaques With MERS Coronavirus

  2013cited by this paper
• Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk

  2013cited by this paper
• Interaction of Ethambutol with Human Organic Cation Transporters of the SLC22 Family Indicates Potential for Drug-Drug Interactions during Antituberculosis Therapy

  2013cited by this paper
• Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study

  2013cited by this paper
• Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential

  2013cited by this paper
• Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

  2013cited by this paper
• Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

  2013cited by this paper
• TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium

  2013cited by this paper
• Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus

  2013cited by this paper
• Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

  2013cited by this paper
• Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia

  2013cited by this paper
• Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding

  2013cited by this paper
• The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies

  2013cited by this paper
• Severe respiratory disease associated with Middle East Respiratory Syndrome Coronavirus ( MERS-CoV ) 6 th update 19 July 2013

  2013cited by this paper
• Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines

  2012cited by this paper
• Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral Helicase

  2012cited by this paper
• Clusters of coronavirus cases put scientists on alert

  2012cited by this paper
• Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

  2012cited by this paper
• Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus

  2011cited by this paper
• IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry

  2011cited by this paper
• Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation.

  2010cited by this paper
• Severe Acute Respiratory Syndrome and Coronavirus

  2010cited by this paper
• Genomic Characterization of Severe Acute Respiratory Syndrome-Related Coronavirus in European Bats and Classification of Coronaviruses Based on Partial RNA-Dependent RNA Polymerase Gene Sequences

  2010cited by this paper
• The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.

  2009cited by this paper
• Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease.

  2009cited by this paper
• Cathepsin L Functionally Cleaves the Severe Acute Respiratory Syndrome Coronavirus Class I Fusion Protein Upstream of Rather than Adjacent to the Fusion Peptide

  2008cited by this paper
• A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

  2008cited by this paper
• Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors

  2008cited by this paper
• Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors

  2007cited by this paper
• Characterization and inhibition of SARS-coronavirus main protease.

  2006cited by this paper
• The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity

  2005cited by this paper
• Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia

  2005cited by this paper
• Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats.

  2005cited by this paper
• Bats Are Natural Reservoirs of SARS-Like Coronaviruses

  2005cited by this paper
• Infectious Entry of West Nile Virus Occurs through a Clathrin-Mediated Endocytic Pathway

  2004cited by this paper
• What’s new in the renin-angiotensin system?

  2004cited by this paper
• Identification of a new human coronavirus

  2004cited by this paper
• Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

  2003cited by this paper
• Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

  2003cited by this paper
• The Severe Acute Respiratory Syndrome

  2003cited by this paper
• The Genome Sequence of the SARS-Associated Coronavirus

  2003cited by this paper
• Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine.

  2003cited by this paper
• The multifunctional or moonlighting protein CD26/DPPIV.

  2003cited by this paper
• Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study.

  2003cited by this paper
• Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

  2003cited by this paper
• Entry of Human Parechovirus 1

  2001cited by this paper
• Functional Importance of the Coiled-Coil of the Ebola Virus Glycoprotein

  2000cited by this paper
• JC Virus Enters Human Glial Cells by Clathrin-Dependent Receptor-Mediated Endocytosis

  2000cited by this paper
• Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.

  1996cited by this paper
• A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein.

  1995cited by this paper
• Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV

  1992cited by this paper
• Human aminopeptidase N is a receptor for human coronavirus 229E

  1992cited by this paper
• Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins.

  1991cited by this paper
• Influence of chlorpromazine on the replication of influenza virus in chick embryo cells.

  1982cited by this paper
• Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.

  1967cited by this paper
• A New Virus Isolated from the Human Respiratory Tract.∗

  1966cited by this paper

• An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

  2024cites this paper
• Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era

  2023cites this paper
• Large scale peptide screening against main protease of SARS CoV‐2

  2022cites this paper
• Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19

  2022cites this paper
• Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination

  2022cites this paper
• COVID-19 Knowledge Extractor (COKE): A Curated Repository of Drug–Target Associations Extracted from the CORD-19 Corpus of Scientific Publications on COVID-19

  2021cites this paper
• Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

  2021cites this paper
• Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy

  2021cites this paper
• A Multidisciplinary Approach to Coronavirus Disease (COVID-19)

  2021cites this paper
• Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks

  2020cites this paper
• COVID-19 Knowledge Extractor (COKE): a tool and a web portal to extract drug - target protein associations from the CORD-19 corpus of scientific publications on COVID-19

  2020cites this paper
• Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease

  2020cites this paper
• Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening and in vitro assays

  2020cites this paper
• COVID-19 pandemic: A description of the readiness & response plan of a tertiary care center in Beirut, Lebanon

  2020cites this paper
• A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

  2020cites this paper
• In silico Repositioning for Dual Inhibitor Discovery of SARS-CoV-2 (COVID-19) 3C-like Protease and Papain-like Peptidase

  2020cites this paper
• Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy

  2020cites this paper
• The broad-spectrum antiviral recommendations for drug discovery against COVID-19

  2020cites this paper
• The recent outbreaks of human coronaviruses: A medicinal chemistry perspective

  2020cites this paper
• Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review

  2020cites this paper
• RNA viruses: clinical and diagnostic features and principles of treatment

  2020cites this paper
• Coronavirus infection in the practice of a general practitioner

  2020cites this paper
• MERS-CoV: Identifying Viral and Host Factors Associated with Transmission, Pathogenesis, and Treatment Development

  2018influential citation
• MERS‐CoV papain-like protease (PLpro): expression, purification, and spectroscopic/thermodynamic characterization

  2017cites this paper
• An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

  2016cites this paper
• Loyola eCommons Loyola eCommons

  year unknowncites this paper